昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

已收盘 12-19 16:08:47

9.000

-0.100

-1.10%

最高9.030	最低8.800	成交量58.39万
今开9.030	昨收9.100	日振幅2.53%
总市值67.41亿	流通市值10.71亿	总股本7.49亿
成交额521.61万	换手率0.49%	流通股本1.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":9,"timestamp":1734595727019,"preClose":9.1,"halted":0,"volume":583853,"delay":0,"floatShares":119000000,"shares":749000000,"eps":0.5685419,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.1,"latestTime":"12-19 16:08:47","open":9.03,"high":9.03,"low":8.8,"amount":5216089,"amplitude":0.025275,"askPrice":9.02,"askSize":8500,"bidPrice":9,"bidSize":9500,"shortable":0,"etf":0,"ttmEps":-0.0012604465715929766,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1614268800000,"adjPreClose":9.1,"dividendRate":0.019071,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.751115,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":17.46,"timestamp":1734591600000,"preClose":17.27,"halted":0,"volume":9297367,"delay":0,"premium":"-51.95"}},"requestUrl":"/m/hq/s/06127/tweets","defaultTab":"tweets","newsList":[{"id":"2492980571","title":"昭衍新药(06127)12月17日耗资187.77万元回购10.9万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492980571","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492980571?lang=zh_cn&edition=full","pubTime":"2024-12-17 16:31","pubTimestamp":1734424288,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)公布，2024年12月17日耗资187.77万元回购10.9万股A股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225928.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06127","399300","BK1576","BK1141","603127","159982","BK0216"],"gpt_icon":0},{"id":"2491538880","title":"昭衍新药（603127）12月13日主力资金净卖出2249.73万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491538880","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491538880?lang=zh_cn&edition=full","pubTime":"2024-12-14 08:23","pubTimestamp":1734135790,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月13日收盘，昭衍新药报收于17.66元，下跌4.23%，换手率3.09%，成交量19.46万手，成交额3.47亿元。12月13日的资金流向数据方面，主力资金净流出2249.73万元，占总成交额6.49%，游资资金净流出2420.85万元，占总成交额6.98%，散户资金净流入4670.59万元，占总成交额13.47%。融券方面，融券卖出2500.0股，融券偿还2.41万股，融券余量12.63万股，融券余额223.0万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121400008188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0216","603127","BK1141","06127"],"gpt_icon":0},{"id":"2491134584","title":"昭衍新药(06127)12月13日斥资88.5万元回购5万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491134584","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491134584?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:32","pubTimestamp":1734078748,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布公告，于2024年12月13日，该公司斥资人民币88.5万元回购5万股A股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","BK1141","06127","159982","BK1576","BK0216","603127"],"gpt_icon":0},{"id":"2490767446","title":"昭衍新药盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490767446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490767446?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:31","pubTimestamp":1733707861,"startTime":"0","endTime":"0","summary":"2024年12月09日早盘09时31分，昭衍新药股票出现波动，股价急速上涨5.03%。截至发稿，该股报9.820港元/股，成交量41.036万股，换手率0.34%，振幅2.14%。昭衍新药股票所在的生物技术行业中，整体涨幅为1.88%。其相关个股中，圣诺医药-B、药明康德、药明生物涨幅较大，振幅较大的相关个股有药明生物、药明康德、乐普生物-B，振幅分别为8.07%、6.50%、4.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093102971ca65f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093102971ca65f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","06127"],"gpt_icon":0},{"id":"2490762502","title":"港股异动 | CRO概念股集体高开 生物安全法案未被列入美参众两院最终版NDAA","url":"https://stock-news.laohu8.com/highlight/detail?id=2490762502","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490762502?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:23","pubTimestamp":1733707405,"startTime":"0","endTime":"0","summary":"消息面上，当地时间12月7日，美国国会参众两院军事委员会公布了2025财年国防授权法案最终协议文本，该版本兼顾了众议院以及参议院两方的提案。NDAA最新版本显示，生物安全法案未被列入其中。按照流程，该版本要获得美国总统签字之后才能生效。招银国国际认为，这意味着生物安全法案试图通过加入NDAA的立法路径失败。生物安全法案仍可以推进单独立法，但考虑到仅剩两周窗口期，该行认为单独立法的成功率极低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221928.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0140636845.USD","LU0516422952.EUR","LU0516423091.SGD","HK0000320223.HKD","LU1242518931.SGD","02269","HK0000306685.HKD","LU0052750758.USD","SG9999002463.SGD","LU1046422090.SGD","BK1589","LU0320764599.SGD","LU0359201612.USD","BK1610","NDAA","HK0000320264.USD","LU0417516902.SGD","LU2242644610.SGD","LU0979878070.USD","LU0307460666.USD","LU0588546209.SGD","BK1521","LU0708995583.HKD","02359","LU0823426308.USD","LU0348825331.USD","BK1583","LU2125910500.SGD","LU0417516738.SGD","LU0039217434.USD","LU0456846285.SGD","LU2045819591.USD","06127","HK0000306701.USD","LU0516423174.USD","LU0823426480.USD","LU0181495838.USD","LU0348735423.USD","IE00B0JY6N72.USD","LU0516422440.USD","LU1794554557.SGD","LU0572944931.SGD","LU0327786744.USD","LU0856984785.SGD","LU1720050803.USD","03759","LU0516422366.SGD","LU1688375341.USD","01548","BK1141"],"gpt_icon":1},{"id":"2489115471","title":"传美国考虑修改生物安全法案 增加对相关公司行政审查环节而非自动禁止生物制药公司与中国公司合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2489115471","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489115471?lang=zh_cn&edition=full","pubTime":"2024-12-06 14:40","pubTimestamp":1733467208,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股集体冲高，药明康德(02359)涨10%，康龙化成(03759)涨7.98%，药明生物(02269)涨6.2%，凯莱英(06821)涨5.95%，昭衍新药(06127)涨5.73%。消息面上，有媒体报道美国生物安全法称，美国立法者正考虑对法案进行更改，妥协版本内容包括增加对相关公司行政审查环节，而非自动禁止生物制药公司与中国公司合作。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949147","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU0516422366.SGD","06127","LU0417516738.SGD","LU1688375341.USD","LU0043850808.USD","LU0307460666.USD","LU0819121731.USD","02359","LU2125910500.SGD","SG9999002463.SGD","LU0039217434.USD","LU0456846285.SGD","LU0823426308.USD","IE00B0JY6N72.USD","LU0516423174.USD","LU0572944931.SGD","LU0708995583.HKD","LU0823426480.USD","LU0327786744.USD","LU0516422952.EUR","BK1576","02269","LU2045819591.USD","BK1583","LU0856984785.SGD","LU0140636845.USD","LU0320764599.SGD","LU0348825331.USD","BK1191","LU0052750758.USD","LU1794554557.SGD","LU2039709279.SGD","06821","LU0051755006.USD","LU0979878070.USD","LU1242518857.USD","LU0348735423.USD","LU0417516902.SGD","LU1242518931.SGD","LU0359202008.SGD","LU0456827905.SGD","LU0516423091.SGD","SG9999002562.SGD","LU2242644610.SGD","LU0588546209.SGD","LU1720050803.USD","03759","LU1046422090.SGD","LU0516422440.USD"],"gpt_icon":0},{"id":"2489473117","title":"港股异动 | CRO概念股涨幅扩大 药明康德(02359)一度升12% 传美国立法者考虑对生物安全法案进行更改","url":"https://stock-news.laohu8.com/highlight/detail?id=2489473117","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489473117?lang=zh_cn&edition=full","pubTime":"2024-12-06 13:35","pubTimestamp":1733463302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股涨幅进一步扩大，截至发稿，药明康德涨10%，报55港元；康龙化成涨8.12%，报14.64港元；药明生物涨7.02%，报17.6港元；昭衍新药涨5.62%，报9.4港元。消息面上，市场消息称，美国立法者正考虑对法案进行更改，妥协版本内容包括增加对相关公司行政审查环节，而非自动禁止生物制药公司与中国公司合作。这些潜在的修订涉及立法中专门点名中国公司的关键部分。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221277.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0417516738.SGD","LU0039217434.USD","LU2039709279.SGD","LU0181495838.USD","603259","LU0516422366.SGD","LU0307460666.USD","BK0216","LU0823426308.USD","LU0572944931.SGD","02269","LU1720050803.USD","02359","BK1589","LU0516423174.USD","LU0856984785.SGD","LU0043850808.USD","LU0348735423.USD","06127","03759","BK1576","LU1688375341.USD","LU0823426480.USD","LU1242518857.USD","SG9999002463.SGD","LU0327786744.USD","LU0819121731.USD","LU1242518931.SGD","LU0456827905.SGD","LU0359201612.USD","LU0326950275.SGD","LU0348825331.USD","LU0588546209.SGD","LU0417516902.SGD","LU0708995583.HKD","BK1141","LU0320764599.SGD","LU1997245177.USD","BK1610","LU0456842615.SGD","LU1046422090.SGD","LU1880383366.USD","LU2488822045.USD","LU1794554557.SGD","SG9999002562.SGD","LU0052750758.USD","IE00B0JY6N72.USD","LU0051755006.USD","BK1521","BK1583"],"gpt_icon":0},{"id":"2489784404","title":"A股CRO概念持续上涨，德展健康涨停，博腾股份涨超9%，药明康德、成都先导涨超8%，康龙化成、昭衍新药、美迪西跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2489784404","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489784404?lang=zh_cn&edition=full","pubTime":"2024-12-06 13:16","pubTimestamp":1733462216,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300363","BK1576","BK0114","300759","LU2242644610.SGD","06127","LU2125910500.SGD","LU0708995583.HKD","603127","LU2488822045.USD","LU0052750758.USD","159982","688202","02359","688222","BK0028","000813","BK0060","BK0216","BK1583","603259","LU1997245177.USD","LU1997245094.SGD","LU0456842615.SGD","03759","LU2045819591.USD","BK1141","LU1046422090.SGD","399300","BK0239","LU0320764599.SGD"],"gpt_icon":0},{"id":"2489421763","title":"港股医药外包概念股集体冲高","url":"https://stock-news.laohu8.com/highlight/detail?id=2489421763","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489421763?lang=zh_cn&edition=full","pubTime":"2024-12-06 11:34","pubTimestamp":1733456082,"startTime":"0","endTime":"0","summary":"每经AI快讯，12月6日，港股医药外包概念股集体冲高，药明康德涨超10%，药明生物涨超8%，昭衍新药涨超7%，康龙化成涨超6%，泰格医药涨超5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412063261312476.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412063261312476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1589","LU0819121731.USD","LU0588546209.SGD","LU0307460666.USD","LU0320764599.SGD","LU0516422440.USD","LU2039709279.SGD","LU0348825331.USD","LU0359201612.USD","LU0326950275.SGD","BK1576","LU0572944931.SGD","LU0516423091.SGD","LU0456827905.SGD","LU0348735423.USD","LU0708995583.HKD","LU0823426308.USD","LU0052750758.USD","IE00B0JY6N72.USD","LU0516422366.SGD","SG9999002463.SGD","LU0823426480.USD","02269","LU0516422952.EUR","LU1720050803.USD","LU0039217434.USD","LU0516423174.USD","LU0856984785.SGD","06127","LU1880383366.USD","LU1242518931.SGD","03347","LU0417516902.SGD","LU0417516738.SGD","LU0140636845.USD","LU1242518857.USD","03759","LU0051755006.USD","BK1141","BK1583","LU0359202008.SGD","LU0181495838.USD","LU0043850808.USD","LU0456846285.SGD","LU0979878070.USD","LU0327786744.USD","LU1794554557.SGD","LU1688375341.USD","BK1521","SG9999002562.SGD"],"gpt_icon":0},{"id":"2489429187","title":"港股医药外包概念股集体冲高，药明康德(02359.HK)涨超10%，药明生物(02269.HK)涨超8%，昭衍新药(06127.","url":"https://stock-news.laohu8.com/highlight/detail?id=2489429187","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489429187?lang=zh_cn&edition=full","pubTime":"2024-12-06 11:28","pubTimestamp":1733455704,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0348735423.USD","06127","LU0456842615.SGD","LU1880383366.USD","LU0348825331.USD","BK0077","LU2488822045.USD","LU1997245094.SGD","BK0028","03347","LU0326950275.SGD","BK1141","LU0979878070.USD","LU0456827905.SGD","LU0359201612.USD","LU0516422366.SGD","LU0052750758.USD","BK1589","LU1242518931.SGD","BK0216","603259","LU0051755006.USD","LU2045819591.USD","LU0320764599.SGD","LU1720050803.USD","BK0174","LU0140636845.USD","BK1576","02269","LU2242644610.SGD","IE00B0JY6N72.USD","LU0043850808.USD","03759","LU0516423091.SGD","LU0572944931.SGD","159718","LU0181495838.USD","BK1521","BK1583","300347","603127","LU0307460666.USD","LU0417516738.SGD","300759","LU1046422090.SGD","LU0516422440.USD","LU1794554557.SGD","02359","LU0588546209.SGD","LU1820825898.SGD"],"gpt_icon":0},{"id":"2489279554","title":"昭衍新药盘中异动 大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489279554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489279554?lang=zh_cn&edition=full","pubTime":"2024-12-06 11:20","pubTimestamp":1733455255,"startTime":"0","endTime":"0","summary":"2024年12月06日早盘11时20分，昭衍新药股票出现异动，股价大幅上涨5.17%。截至发稿，该股报9.360港元/股，成交量82.0892万股，换手率0.69%，振幅5.51%。昭衍新药股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，北海康成-B、巨子生物、云康集团涨幅较大，振幅较大的相关个股有北海康成-B、来凯医药-B、永泰生物-B，振幅分别为29.23%、13.75%、13.30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120611205598e5c1d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120611205598e5c1d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","06127"],"gpt_icon":0},{"id":"2488157677","title":"云南白药拟50亿做LP，2024年医药企业产业基金投向哪里？","url":"https://stock-news.laohu8.com/highlight/detail?id=2488157677","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488157677?lang=zh_cn&edition=full","pubTime":"2024-12-04 17:06","pubTimestamp":1733303169,"startTime":"0","endTime":"0","summary":"中新经纬12月4日电 (王玉玲)近日，云南白药公告称，拟出资50亿元与中银国际投资有限责任公司(下称中银国际投资)共同投资设立产业基金，该基金目标认缴出资总额为70亿元。　　云南白药此前曾因二级市场炒股失利导致巨额亏损。今年1月，云南白药披露投资者调研会议记录称，已于2023年三季度退出全部二级市场证券投资，并计划...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OLS6AFzvsx_nnRjSIwFS1ZnnzP0mEkC7fKiV6gziCNrygAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OLS6AFzvsx_nnRjSIwFS1ZnnzP0mEkC7fKiV6gziCNrygAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241204A076C700","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241204A076C700","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1576","BK1593","BK1515","BK1191","02196","BK1141","06127"],"gpt_icon":0},{"id":"2488620955","title":"昭衍新药已回购210万股 累计回购金额3320万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488620955","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488620955?lang=zh_cn&edition=full","pubTime":"2024-12-02 19:06","pubTimestamp":1733137569,"startTime":"0","endTime":"0","summary":"根据公告，公司自2024年3月29日首次披露回购方案以来，回购金额预计在5000万元至1亿元之间。截至2024年11月30日，公司累计已回购股数为210万股，占总股本的0.2806%，累计回购金额为3320万元，回购价格区间在13.2元/股至18.15元/股。公司在回购期间将按规定定期披露回购进展情况，并表示截至公告日未回购A股股份。2024年前三季度，昭衍新药实现收入13.35亿元，归母净利润-7031万元。文章来源：财中社昭衍新药已回购210万股 累计回购金额3320万元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202192648a2663161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202192648a2663161&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","603127","BK0216"],"gpt_icon":0},{"id":"2488925627","title":"昭衍新药：累计回购约210万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488925627","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488925627?lang=zh_cn&edition=full","pubTime":"2024-12-02 18:53","pubTimestamp":1733136782,"startTime":"0","endTime":"0","summary":"每经AI快讯，昭衍新药12月2日晚间发布公告称，截至2024年11月30日，公司累计通过集中竞价交易方式回购A股股份约210万股，占公司本公告日总股份的0.2806%，回购最高价格为人民币18.15元/股，回购最低价格为人民币13.2元/股，使用资金总额为人民币约3320万元。昭衍新药的董事长是冯宇霞，女，60岁，学历背景为硕士；总经理是高大鹏，男，42岁，学历背景为本科。每经头条（nbdtoutiao）——任务完不成，每周扣1000元！有银行客户经理吐槽“大家都等着降级”！有人一个季度绩效1万元，他说：工作压力很大(记者 曾健辉)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202185402a2661d38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202185402a2661d38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06127","BK1141","603127"],"gpt_icon":0},{"id":"2488626271","title":"昭衍新药(06127)累计回购A股股份210.31万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488626271","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488626271?lang=zh_cn&edition=full","pubTime":"2024-12-02 17:12","pubTimestamp":1733130732,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布公告，2024年11月，公司未回购A股股份。截至2024年11月30日，公司累计通过集中竞价交易方式回购A股股份210.31万股，占公司本公告日总股份的0.2806%，回购最高价格为人民币18.15元/股，回购最低价格为人民币13.20元/股，使用资金总额为人民币3319.6万元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","BK1576","06127","159982","BK1141","BK0216","603127"],"gpt_icon":0},{"id":"2488625175","title":"昭衍新药12月02日主力资金流入15万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2488625175","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488625175?lang=zh_cn&edition=full","pubTime":"2024-12-02 16:17","pubTimestamp":1733127433,"startTime":"0","endTime":"0","summary":"12月02日, 昭衍新药股价涨0.87%，报收9.28元，成交金额1131万元，换手率1.03%，振幅2.83%，量比1.23。昭衍新药今日主力资金净流入15万元，连续3日净流入，上一交易日主力净流入73万元，今日环比减少79.45%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为50.00%，平均涨幅为5.05%。该股近5个交易日下跌0.96%，主力资金累计净流入49万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入97万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161753a265bc5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161753a265bc5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","06127","BK1576"],"gpt_icon":0},{"id":"2486353313","title":"南向资金11月27日净买入昭衍新药5.44万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2486353313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486353313?lang=zh_cn&edition=full","pubTime":"2024-11-28 09:30","pubTimestamp":1732757418,"startTime":"0","endTime":"0","summary":"11月27日, 南向资金增持昭衍新药5.44万股，连续3日增持。截止当日收盘，港股通共持有昭衍新药4339.62万股，占流通股36.46%。昭衍新药近5个交易日下跌3.20%，港股通累计增持37.26万股；近20个交易日上涨9.50%，港股通累计增持281.29万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128093229abe48732&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128093229abe48732&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","603127","06127"],"gpt_icon":0},{"id":"2486862184","title":"港股异动 | CRO概念股早盘回暖 海外投融资逐渐恢复 医药细分领域及新兴业务有望快速发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2486862184","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486862184?lang=zh_cn&edition=full","pubTime":"2024-11-27 11:02","pubTimestamp":1732676570,"startTime":"0","endTime":"0","summary":"西南证券发布研报称，2024年前三季度，CXO行业收入逐季回升，但利润整体仍有承压。受益于国内CXO产业链的全面以及竞争力的领先，行业受地缘政治影响目前较为有限。国内临床前及临床CRO价格趋稳，经营趋势有望逐渐向上。近年来在ADC、多肽药物快速发展下，相关CXO需求迅速增加，小核酸、CGT等细分领域也有望迎来快速发展。长期来看，我们仍旧看好CXO板块发展潜力及成长空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01521","BK1576","LU0823426308.USD","LU1688375341.USD","LU0348825331.USD","LU0417516738.SGD","BK1521","LU0456846285.SGD","HK0000306701.USD","LU0823426480.USD","LU0359201612.USD","02269","LU0052750758.USD","03347","LU0516423174.USD","LU0417516902.SGD","HK0000306685.HKD","IE00B0JY6N72.USD","BK1515","LU0326950275.SGD","LU0588546209.SGD","BK1610","LU0979878070.USD","LU1242518931.SGD","LU1794554557.SGD","LU0307460666.USD","LU0819121731.USD","LU0856984785.SGD","LU0516422366.SGD","LU0708995583.HKD","BK1589","LU0043850808.USD","159938","LU0456827905.SGD","09939","06127","LU0516423091.SGD","SG9999002562.SGD","LU0039217434.USD","LU0327786744.USD","LU0181495838.USD","01548","BK1583","BK1141","LU0359202008.SGD","SG9999002463.SGD","LU0320764599.SGD","HK0000320264.USD","BK1161","BK1574"],"gpt_icon":0},{"id":"2486716360","title":"昭衍新药：12月4日将召开2024年第三季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486716360","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486716360?lang=zh_cn&edition=full","pubTime":"2024-11-26 20:10","pubTimestamp":1732623038,"startTime":"0","endTime":"0","summary":"证券日报网讯11月26日晚间，昭衍新药发布公告称，公司计划于2024年12月4日下午16：00—17：00举行2024年第三季度业绩说明会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411263251252746.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","BK1141","BK1576"],"gpt_icon":0},{"id":"2485231241","title":"昭衍新药（603127）11月22日主力资金净卖出1985.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485231241","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485231241?lang=zh_cn&edition=full","pubTime":"2024-11-23 08:23","pubTimestamp":1732321404,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月22日收盘，昭衍新药报收于17.68元，下跌6.16%，换手率1.96%，成交量12.36万手，成交额2.25亿元。11月22日的资金流向数据方面，主力资金净流出1985.76万元，占总成交额8.83%，游资资金净流出839.45万元，占总成交额3.73%，散户资金净流入2825.21万元，占总成交额12.56%。融券方面，融券卖出1100.0股，融券偿还1700.0股，融券余量20.46万股，融券余额361.69万元。昭衍新药主营业务：非临床研究服务,临床研究服务,实验模型服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112300006483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0216","BK1141","06127","603127"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0411},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.3382},{"period":"6month","weight":0.1632},{"period":"1year","weight":-0.2037},{"period":"ytd","weight":-0.2755}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。非临床研究服务包括药物安全性评价、药代动力学研究以及药理和药效学研究。临床试验及相关服务包括临床合同研究组织服务、一期临床研究协作单位 (CRU)，以及生物分析服务。实验模型业务主要包括啮齿类及非人灵长类动物。该公司在国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.116169},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.004245},{"month":3,"riseRate":0.25,"avgChangeRate":-0.021642},{"month":4,"riseRate":0.25,"avgChangeRate":-0.064961},{"month":5,"riseRate":0.75,"avgChangeRate":0.028518},{"month":6,"riseRate":0.5,"avgChangeRate":0.026858},{"month":7,"riseRate":0.75,"avgChangeRate":0.036307},{"month":8,"riseRate":0,"avgChangeRate":-0.164063},{"month":9,"riseRate":0.5,"avgChangeRate":0.001124},{"month":10,"riseRate":0.25,"avgChangeRate":-0.061345},{"month":11,"riseRate":0.5,"avgChangeRate":0.080654},{"month":12,"riseRate":0.25,"avgChangeRate":-0.064237}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}